Suzuken Co Ltd - Company Profile
Powered by 
All the data and insights you need on Suzuken Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Suzuken Co Ltd Strategy Report
- Understand Suzuken Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View up-to-date information on Suzuken Co Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| AU2021212949A1 | Application | Antisense oligonucleotide of ATN1 | A61K31/7088; A61K31/711; A61K31/7115; A61K31/712; A61K31/7125; A61K48/00; A61P25/00; A61P25/08; A61P25/14; A61P25/18; A61P25/28; A61P43/00; C07K14/435; C12N15/11; C12N15/113; C12N5/10 | September 01, 2022 |
| CN114929876A | Application | ATN1的反义寡核苷酸 | A61K31/7088; A61K31/711; A61K31/7115; A61K31/712; A61K31/7125; A61K48/00; A61P25/00; A61P25/08; A61P25/14; A61P25/18; A61P25/28; A61P43/00; C07K14/435; C12N15/11; C12N15/113; C12N5/10 | August 19, 2022 |
| JP2022120851A | Application | グリコピロニウム・サリチル酸塩を含む医薬 | A61K31/40; A61K31/60; A61K9/70; A61P1/02; A61P25/00; C07D207/12 | August 18, 2022 |
| WO2022168940A1 | Application | PHARMACEUTICAL COMPRISING GLYCOPYRRONIUM-SALICYLATE | August 11, 2022 | |
| EP4019965A1 | Application | VERFAHREN ZUR BESTIMMUNG DER KONZENTRATION EINER PERESSIGSÄUREFORMULIERUNG | G01N21/293; G01N21/78; G01N31/00; G01N31/22; G01N33/02 | June 29, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward